Dr. Emil F. Kendziorra is a founder and CEO at Tomorrow Bio and President of the Board at the European Biostasis Foundation, a non-profit research foundation and institute in Switzerland. He has been leading multiple tech and medical companies, most recently as Founder and CEO of Medlanes (Exit to ZAVA) and onFeedback (Exit to QuestionPro). Prior to his career in entrepreneurship, Emil graduated summa cum laude in medicine from University Medical Center Göttingen, with a doctoral degree in translational cancer research. He’s a regular keynote speaker on future of healthcare, the overlap of healthcare, science and technology as well as a mentor to tech startups and an investor via Lightcone Capital. Emil has decided to dedicate the next decades of this life to human cryopreservation and biostasis..
„Wir sind heute auf der Titelseite von Spiegel Online. Wie immer biete ich allen Kritikern im Artikel gerne eine Oxford-style Debate an“, postete Dr. Emil Kendziorra, Gründer und CEO des Kryonik-Start-ups Tomorrow Bio, letzten Herbst auf X. Die soll er beim Festival der Zukunft h…
